What are the recommended treatment options for a lip hemangioma?

Treatment for Lip Hemangioma

Oral propranolol is the first-line treatment for lip infantile hemangiomas that cause or are likely to cause functional impairment or disfigurement. 1

First-Line Treatment: Oral Propranolol

Propranolol has become the standard of care for complicated infantile hemangiomas (IH) since 2008, replacing systemic corticosteroids as the primary therapeutic agent. 1

Indications for Propranolol in Lip Hemangiomas

Lip hemangiomas specifically warrant treatment with propranolol when they cause:

• Functional impairment - particularly feeding difficulties, which occur in up to 82% of untreated cases 1
• Actual or potential disfigurement - even relatively small lip hemangiomas can lead to permanent and stigmatizing changes 1
• Ulceration - lip hemangiomas have approximately 50% risk of ulceration, which is painful and leads to scarring 1

Dosing Protocol

• Starting dose: 0.5 mg/kg/day, then titrate up 1
• Target dose: 2 mg/kg/day divided into 2-3 daily doses 1, 2
• Maximum dose: 3 mg/kg/day for non-responders 1
• Duration: Most patients can stop at 1 year of age; majority don't need treatment beyond 17 months 1

Important caveat: Lip hemangiomas involving the vermilion border have worse outcomes and require longer treatment compared to lesions confined to one side of the vermilion. 2

Second-Line Treatment: Intralesional Corticosteroids

Intralesional injection of triamcinolone and/or betamethasone is recommended specifically for focal, bulky lip hemangiomas during proliferation. 3

This modality is particularly suited for lip hemangiomas because:

• The lip is identified as a "critical anatomic location" where localized treatment is advantageous 3
• It targets focal, well-localized lesions where proliferation threatens anatomic landmarks 3
• It avoids systemic exposure when treating smaller lesions 3

Risks of Intralesional Steroids

• Local skin complications including fat/dermal atrophy and pigmentary changes 3
• Transient Cushingoid features 3
• Adrenal suppression with large doses (>4 mg/kg) 3
• Critical warning: Rare reports of central retinal artery embolization with upper eyelid injections due to high injection pressures 3

Third-Line: Topical Timolol

Topical timolol maleate may be used for thin and/or superficial lip hemangiomas. 3

However, this is less applicable to most lip hemangiomas, which tend to be bulky and mixed depth. Best responses occur in lesions <1 mm thick. 3

Alternative: Oral Corticosteroids

Oral prednisolone or prednisone may be prescribed if there are contraindications or inadequate response to propranolol. 3

This provides modest benefit (43% mean clearance rate) but has clinically important harms including growth suppression and metabolic effects. 3

Surgical Management

Surgery should be considered in specific circumstances:

Early Surgical Resection (During Proliferative Phase)

Early resection during the proliferative phase should be considered to prevent complications associated with delayed treatment. 4

A retrospective study comparing early versus late resection found:

• Patients in the involutional group experienced higher complication rates: bleeding (45% vs 10%), speech impairment (82% vs 0%), feeding difficulties (82% vs 20%) 4
• 82% of patients in the involutional group required speech therapy 4
• Transverse elliptical vermilion-mucosal resection technique yields acceptable aesthetic results in both phases 4

Combined Approaches

For larger cavernous hemangiomas, a combined approach using intralesional Nd:YAG laser photocoagulation followed immediately by surgical excision minimizes bleeding and shrinks the lesion before removal. 5

Treatment Algorithm

1. First assess: Determine if treatment is needed based on functional impairment, disfigurement risk, or ulceration 1

2. First-line: Initiate oral propranolol 2 mg/kg/day for most lip hemangiomas causing complications 1

3. Consider intralesional steroids: For focal, bulky lesions where localized treatment is preferred 3

4. Consider early surgery: If hemangioma is causing significant feeding difficulties or speech concerns, or if medical therapy fails 4

5. Reserve topical timolol: Only for thin, superficial components 3

Common Pitfalls

• Delaying treatment: Waiting for spontaneous involution in lip hemangiomas often leads to speech impairment, feeding difficulties, and psychosocial issues that could have been prevented 4
• Underestimating vermilion border involvement: These lesions require longer treatment and have poorer prognosis 2
• Using propranolol for ulcerated hemangiomas beyond growth phase: Propranolol can worsen ulceration through peripheral ischemia; dose reduction or alternative therapy needed 1